|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| New Shire Income Access Share Trust | |||||
| Total net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share based compensation | |||||
| Amortization of deferred financing fees | |||||
| Expense related to the unwind of inventory fair value adjustments | |||||
| Change in deferred taxes | |||||
| Equity in losses/(earnings) of equity method investees | |||||
| Write down of PP&E | |||||
| Write down of assets | |||||
| Gain on sale of product rights | |||||
| Total gain on sale of product rights | |||||
| Change in fair value of contingent consideration | |||||
| Impairment of intangible assets | |||||
| Goodwill impairment charge | |||||
| Total goodwill impairment charge | |||||
| Impairment of PP&E and intangible assets | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in accounts receivable | |||||
| Increase in sales deduction accrual | |||||
| Increase in inventory | |||||
| Decrease/(increase) in prepayments and other assets | |||||
| (Decrease)/increase in accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| New Shire Income Access Share Trust | |||||
| Total net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of PP&E | |||||
| Purchases of businesses, net of cash acquired | |||||
| Purchases of non-current investments and PP&E | |||||
| Proceeds from sale of investments | |||||
| Proceeds received on sale of product rights | |||||
| Movements in restricted cash | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| New Shire Income Access Share Trust | |||||
| Total net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from revolving line of credit, long term and short term borrowings | |||||
| Repayment of revolving line of credit, long term and short term borrowings | |||||
| Repayment of debt acquired through business combinations | |||||
| Proceeds from ViroPharma call options | |||||
| Payment of dividend | |||||
| Payments to acquire shares (in USD) | |||||
| EBT | |||||
| Share Buy-back Program | |||||
| Excess tax benefit associated with exercise of stock options | |||||
| Debt issuance costs | |||||
| Contingent consideration payments | |||||
| Proceeds from issuance of stock for share-based compensation arrangements | |||||
| Other, net | |||||
| Distributions made | |||||
| Net cash (used in)/provided by financing activities | |||||
| New Shire Income Access Share Trust | |||||
| Total net cash (used in)/provided by financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| New Shire Income Access Share Trust | |||||
| Total net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| New Shire Income Access Share Trust | |||||
| Total cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| New Shire Income Access Share Trust | |||||
| Total cash and cash equivalents at end of period | |||||
| Supplemental information: | |||||
| Interest paid | |||||
| Income taxes repaid | |||||
| Income taxes (paid)/received | |||||
| Receipt of break fee | |||||
| Income taxes paid, net | |||||
Loading...